Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling.
Peters S, Kuespert S, Wirkert E, Heydn R, Jurek B, Johannesen S, Hsam O, Korte S, Ludwig FT, Mecklenburg L, Mrowetz H, Altendorfer B, Poupardin R, Petri S, Thal DR, Hermann A, Weishaupt JH, Weis J, Aksoylu IS, Lewandowski SA, Aigner L, Bruun TH, Bogdahn U. Peters S, et al. Among authors: mecklenburg l. Neurotherapeutics. 2021 Jul;18(3):1963-1979. doi: 10.1007/s13311-021-01045-2. Epub 2021 Apr 15. Neurotherapeutics. 2021. PMID: 33860461 Free PMC article.
Save Your Maximum Tolerated Dose: How to Diagnose Procedure-Related Spinal Cord Lesions After Lumbar Intrathecal Bolus Administration of Oligonucleotides in Cynomolgus Monkeys.
Korte S, Luft J, von Keutz A, Runge F, Mecklenburg L, Wozniak MM, Zander S, Ludwig FT, Pajaziti B, Romeike A, Korytko P. Korte S, et al. Among authors: mecklenburg l. Int J Toxicol. 2020 Nov/Dec;39(6):510-517. doi: 10.1177/1091581820951098. Epub 2020 Aug 28. Int J Toxicol. 2020. PMID: 32856507
Safe and Effective Cynomolgus Monkey GLP-Tox Study with Repetitive Intrathecal Application of a TGFBR2 Targeting LNA-Gapmer Antisense Oligonucleotide as Treatment Candidate for Neurodegenerative Disorders.
Peters S, Wirkert E, Kuespert S, Heydn R, Johannesen S, Friedrich A, Mailänder S, Korte S, Mecklenburg L, Aigner L, Bruun TH, Bogdahn U. Peters S, et al. Among authors: mecklenburg l. Pharmaceutics. 2022 Jan 15;14(1):200. doi: 10.3390/pharmaceutics14010200. Pharmaceutics. 2022. PMID: 35057094 Free PMC article.
Research Relevant Conditions and Pathology in Nonhuman Primates.
Saravanan C, Flandre T, Hodo CL, Lewis AD, Mecklenburg L, Romeike A, Turner OC, Yen HY. Saravanan C, et al. Among authors: mecklenburg l. ILAR J. 2020 Dec 31;61(2-3):139-166. doi: 10.1093/ilar/ilab017. ILAR J. 2020. PMID: 34129672 Free PMC article. Review.
45 results